The latest cannabis news across Australia covering all states and all topics.
What do budding business-minded people do when they see an opportunity ripe for the taking? They take it. And that’s exactly what some of Vietnam’s largest and most sophisticated criminal networks have done with Australia’s cannabis black market. Keep Reading
Have you ever wondered why data on medical cannabis is so difficult to access in Australia? The Therapeutic Goods Administration (TGA) may have accidentally revealed the answer during an interview with Health Europa’s Medical Cannabis Network (MCN). Keep Reading
Australia has some well organised criminal structures supplying the vast majority of the black market. And then there’s these folks. The not so organised, the not so smart, and well, just a little bit dumb. Keep Reading
Australian and Maltanese Autism treatment company Neurotech believes a small group of unique cannabis strains may be more effective at treating neurological conditions than CBD. Keep Reading
Sydney-based analytics company Freshleaf Analytics has released their Q3 report, predicting that patients will spend $95 million on medical cannabis products in 2020. Keep Reading
Part of the TGA’s job description is to make sure medicinal cannabis products are up to standard. To check those standards, they recently tested 22 medicinal cannabis products available to Australian patients. Keep Reading
VFL player Ryan Gale has spoken out in favour of using medical cannabis to treat chronic pain in athletes. Keep Reading
Australian pharmaceutical company Althea Group Holdings (ASX: AGH) has announced plans to enter the cannabis-infused beverage market, through their Canadian subsidiary. Keep Reading
A special edition of the Global Drug Survey (GDS) was conducted earlier this year, aiming to measure changes in drug consumption worldwide throughout the coronavirus pandemic. The results were published on Wednesday. Keep Reading
In an exciting new development, Australia’s Therapeutic Goods Administration (TGA) has announced plans to reschedule low-dose CBD products in 2021. Keep Reading
